Clinical Trial Detail

NCT ID NCT02883062
Title Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Paclitaxel

Atezolizumab + Carboplatin + Paclitaxel

Age Groups: adult senior

No variant requirements are available.